EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Dosimetric comparison of scanned proton therapy and volumetric modulated arc therapy in isodose-prescribed stereotactic body radiotherapy for lung cancer

Yuki Tominaga iD, Hiromitsu Endo, Takahiro Kato, Yushi Wakisaka, Tatsuyuki Higashikawa, Masao Murakami iD, Michinori Yamamoto

Journal of Radiation Research · 2026

DOI: 10.1093/jrr/rraf091 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Radiation Research, 2026. Verfasst von Yuki Tominaga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Medical Co. Hakuhokai, Osaka Proton Therapy Clinic, 1-27-9, Kasugadenaka, Konohana-Ku, Osaka 554-0022, Japan. Hauptthemen laut MEDLINE: Lung Neoplasms, Proton Therapy, Radiosurgery, Radiotherapy, Intensity-Modulated. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the feasibility of pencil beam scanning (PBS) proton therapy for stereotactic body radiotherapy using an isodose prescription in patients with isolated early-stage lung cancer, comparing dose–volume metrics with those of volumetric modulated arc therapy (VMAT). Treatment plans were generated for 10 patients with tumors located at least 2 cm from the trachea. Each plan prescribed 48 Gy(RBE) in four fractions with a 60% isodose prescription. Both multi-field optimized and single-field optimized PBS plans used four fields, while VMAT plans used two coplanar arcs. Plan robustness was assessed by simulating setup errors of ±5.0 mm and density uncertainties of ±3.5%, with worst-case target coverage also analyzed. Comparisons among the three planning strategies employed Bonferroni-adjusted multiple comparisons for target coverage, robustness, and organ-at-risk doses. PBS achieved target coverage comparable to VMAT, with similar D98% (63.2 ± 1.3 GyRBE vs. 64.0 ± 1.6 Gy; P = 0.12), mean doses (73.2 ± 0.8 GyRBE vs. 73.7 ± 1.2 Gy; P = 0.21), and robustness (D98%: 50.2 ± 0.9 GyRBE vs. 50.3 ± 1.1 Gy; P = 0.77). For the normal lung, PBS significantly reduced low-dose exposure up to V10Gy, whereas VMAT was more effective in reducing doses from V20Gy to the prescription level. All evaluated organ-at-risks received significantly lower mean doses with PBS than with VMAT (P < 0.05). Under a 60% isodose prescription for lung stereotactic body radiotherapy, multi-field optimized-based PBS proton therapy provides target coverage and robustness comparable to VMAT while offering superior normal tissue sparing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsProton TherapyRadiosurgeryRadiotherapy, Intensity-ModulatedHumansRadiotherapy DosageRadiotherapy Planning, Computer-AssistedRadiometry

Stichwörter der Autor:innen

lung cancerpencil beam scanningproton therapystereotactic body radiotherapytreatment planning

Autor:innen und Institutionen

  • Department of Radiotherapy, Medical Co. Hakuhokai, Osaka Proton Therapy Clinic, 1-27-9, Kasugadenaka, Konohana-Ku, Osaka 554-0022, Japan.
  • Medical Physics Laboratory, Division of Health Science, Graduate School of Medicine, The University of Osaka, 1-7 Yamadaoka, Suita-Shi, Osaka 565-0871, Japan.
  • Department of Radiation Physics and Technology, Southern Tohoku General Hospital, 115, Yatsuyamada 7 Chome, Koriyama, Fukushima 963-8563, Japan.
  • Department of Radiation Physics and Technology, Southern Tohoku Proton Therapy Center, 172, Yatsuyamada 7 Chome, Koriyama, Fukushima 963-8052, Japan.
  • Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakae-machi, Fukushima, Fukushima 960-8516, Japan.
  • Department of Radiation Oncology, Medical Co. Hakuhokai, Osaka Proton Therapy Clinic, 1-27-9, Kasugadenaka, Konohana-Ku, Osaka 554-0022, Japan.

ORCID-Profile: Yuki Tominaga, Masao Murakami

Förderung

  • JSPS KAKENHI

Zitieren

APA

Tominaga, Y., Endo, H., Kato, T., Wakisaka, Y., Higashikawa, T., Murakami, M., & Yamamoto, M. (2026). Dosimetric comparison of scanned proton therapy and volumetric modulated arc therapy in isodose-prescribed stereotactic body radiotherapy for lung cancer. Journal of Radiation Research. https://doi.org/10.1093/jrr/rraf091

Vancouver

Tominaga Y, Endo H, Kato T, Wakisaka Y, Higashikawa T, Murakami M, et al. Dosimetric comparison of scanned proton therapy and volumetric modulated arc therapy in isodose-prescribed stereotactic body radiotherapy for lung cancer. Journal of Radiation Research. 2026. doi:10.1093/jrr/rraf091

BibTeX
@article{Tominaga2026,
  author = {Tominaga, Yuki and Endo, Hiromitsu and Kato, Takahiro and Wakisaka, Yushi and Higashikawa, Tatsuyuki and Murakami, Masao and Yamamoto, Michinori},
  title = {Dosimetric comparison of scanned proton therapy and volumetric modulated arc therapy in isodose-prescribed stereotactic body radiotherapy for lung cancer},
  journal = {Journal of Radiation Research},
  year = {2026},
  doi = {10.1093/jrr/rraf091}
}
Kostenlos starten →